You searched for "inflammation"
Optimising the ocular surface by managing meibomian gland dysfunction
1 February 2016
| Teifi James
|
EYE - Cornea
Meibomian gland dysfunction (MGD) is ubiquitous. Ocular surface inflammation and irritation are prevalent in most ophthalmology clinics: corneal, cataract, glaucoma, oculoplastic, paediatric, vitreo-retinal, medical retina and refractive surgery. These patients also represent roughly one third of those attending for emergency...
Chronic lymphocytic leukaemia (CLL) of the lacrimal sac
The authors present a case series of three patients with known CLL, two of which presented with mass and epiphora and one case with epiphora alone. All three patients had initially being diagnosed and were treated for chronic dacryocystitis. Histopathological...The results of the last survey Feb24
2 February 2024
| Amar Alwitry
|
EYE - Vitreo-Retinal
Thank you to all those who participated in this edition’s survey and for those of you who attended my recent Medico-legal Seminar at the Royal College of Ophthalmologists. It was a fascinating and educational day, made a success by the...
The challenge of chorioretinal folds in virtual eye clinics
3 June 2024
| Noorulain Khalid, Faizan Hashmi, Adam Riaz, Hadi Ziaei, Abha Gupta
|
EYE - Vitreo-Retinal, EYE - Orbit
Chorioretinal or choroidal folds are parallel striations involving the retina, retinal pigment epithelium (RPE), Bruch’s membrane, and inner choroid [1]. They can arise from compressive stress on these layers, and their presence often serves as a diagnostic marker for underlying...
Deciphering dark retinal patches
3 October 2024
| Blanca Flores, Anastassios Kostakis
|
EYE - Vitreo-Retinal
We present a case of bilateral extensive dark without pressure (DWP) located outside the retinal vascular arcades in a young female. This retinal finding is benign but, in some instances, darkened retinal patches could be associated with potential sight-threatening conditions....
Insights in resistant diabetic macular oedema
5 August 2022
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This article gives a bird’s eye review of the different modalities for the treatment of diabetic macular oedema (DME). The debut of anti-VEGFs has brought a paradigm shift in DME management. This treatment has now become a major breakthrough in...
Orbital cellulitis - an overview of the diagnosis and management
1 February 2022
| Mohammad Farwana
|
EYE - Orbit, EYE - Neuro-ophthalmology, EYE - Imaging, EYE - General
Periorbital (preseptal) and orbital cellulitis are infections of the subcutaneous tissues of the eye. They are differentiated by the location of the infection. Periorbital cellulitis refers to infection of the eyelid and subcutaneous tissues anterior to the orbital septum, whereas...
Clinical evaluation of a multifocal aspheric diffractive intraocular lens
1 February 2014
| Jonathan Chan
|
EYE - Cataract, EYE - Refractive
|
Lens and zonules, Optics and Refraction, Treatment Surgery
This is a multi-centre prospective study involving five different centres in Europe including 52 patients with cataract. The average age was 68.5±10.5 years, 35 females were bilateral implanted with aspheric diffractive multifocal lens implantation of the Tecnis 1-Piece multifocal intraocular...
Pupil abnormalities after orbital surgery
This is a retrospective review of 287 patients who underwent removal of an orbital cavernous haemangioma (cavernous venous malformation), to ascertain the incidence of surgically induced pupillary abnormalities. Forty-four patients had lesions removed from the anterior or extraconal orbit, none...AI insights lead OSA lecture programme
Ophthalmology’s role at the forefront of many areas of healthcare, providing valuable insights to early disease markers and progression, is to be highlighted on the OSA stand at 100% Optical. Some seven hours of free to attend lectures will provide a vision of the next five years of High Street practice.Boosting key protein in eye cells could prevent age-related vision loss, international team finds
Increasing the levels of a key protein in the cells at the back of the eye could help protect against the leading cause of vision loss among older adults, finds a new discovery made by researchers from the UK, US, Germany and Australia.ABDO announces groundbreaking therapy for contact lens opticians
1 October 2024
|
novel therapies, contact lens, ABDO, optometry, optician, research, new studies, Omnigen, Omnilenz, NuVision, Andy Hill
The Association of British Dispensing Opticians (ABDO) has given the go ahead for contact lens opticians to prescribe a groundbreaking new therapy, enabling ~1,700 new practitioners to offer the treatment to their patients. NuVision Biotherapies, a UK based tissue-therapy company...
